Vol 6, No 3 (June 29, 2017): Translational Lung Cancer Research (Malignant Pleural Mesothelioma: Updates and New Directions)

Review Article

In vitro experimental models of mesothelioma revisited
Anand Singh, Nathanael Pruett, Chuong D. Hoang
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update
Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang
BAP1, a tumor suppressor gene driving malignant mesothelioma
Mitchell Cheung, Joseph R. Testa
Intraoperative near-infrared imaging of mesothelioma
Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal
Intraoperative adjuncts for malignant pleural mesothelioma
Warren Ho Chan, David J. Sugarbaker, Bryan M. Burt
Novel systemic therapy against malignant pleural mesothelioma
Michael R. Mancuso, Joel W. Neal
Immunotherapy for malignant pleural mesothelioma: current status and future directions
Jordan Dozier, Hua Zheng, Prasad S. Adusumilli
Radio-immunotherapy and chemo-immunotherapy as a novel treatment paradigm in malignant pleural mesothelioma
Licun Wu, Marc de Perrot
Drug development against the hippo pathway in mesothelioma
Gavitt A. Woodard, Yi-Lin Yang, Liang You, David M. Jablons
Targeting eukaryotic protein translation in mesothelioma
Robert A. Kratzke
Targeting the epigenome in malignant pleural mesothelioma
Kaitlin C. McLoughlin, Andrew S. Kaufman, David S. Schrump

Review Article

Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology
Cesare Gridelli, Andrea Ardizzoni, Massimo Barberis, Federico Cappuzzo, Francesca Casaluce, Romano Danesi, Giancarlo Troncone, Filippo De Marinis

Case Report

Do we really care about incidental lung nodules?—Review of atypical lung carcinoid and a proposal for systematic patient follow up
Henal Motiwala, Itisha Bansal, Pradeep Goyal, Olena Dorokhova, Yogesh Kumar, Thomas D. Olsavsky, Albert DiMeo, Nishant Gupta


The focused issue “Malignant Pleural Mesothelioma: Updates and New Directions” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Chuong D. Hoang served as the unpaid Guest Editor for the focused issue.